Misplaced Pages

CoCo Therapeutics

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
UK-based biotechnology company

CoCo Therapeutics
IndustryPharmaceutical industry
FoundedUnited Kingdom (2013 (2013))
HeadquartersUnited Kingdom
Websitecocotherapeutics.com

CoCo Therapeutics is a United Kingdom-based biotechnology company formed in 2013 jointly by King's College London, the Wellcome Trust and Advent Venture Partners. The company will focus on development of therapeutics for Alzheimer's disease which target retinoic acid receptor alpha, specifically building on work originating in the Neuroscience Drug Discovery Unit of King's College, led by Jonathan Corcoran. This work was funded through the Wellcome Trust's Seeding Drug Discovery Initiative.

References

  1. ^ "New U.K. Biotech Firm CoCo Therapeutics Takes on Alzheimer's". Genetic Engineering & Biotechnology News (paper). 1 April 2013. p. 12.
  2. "New drug discovery company for Alzheimer's research" (Press release). King's College University. 3 April 2013. Retrieved 4 July 2013.
  3. "Company created to progress experimental Alzheimer's disease therapy" (Press release). Wellcome Trust. 5 March 2013. Retrieved 4 July 2013.


Stub icon

This article about a company of the UK is a stub. You can help Misplaced Pages by expanding it.

Categories: